Parietal resting-state EEG alpha source connectivity is associated with subcortical white matter lesions in HIV-positive people.

Human immunodeficiency virus (HIV) Low-resolution brain electromagnetic source tomography (LORETA) Magnetic resonance imaging (MRI) Resting state EEG rhythms

Journal

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
ISSN: 1872-8952
Titre abrégé: Clin Neurophysiol
Pays: Netherlands
ID NLM: 100883319

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 25 02 2020
revised: 07 08 2023
accepted: 21 09 2023
pubmed: 17 10 2023
medline: 17 10 2023
entrez: 16 10 2023
Statut: ppublish

Résumé

Parietal resting-state electroencephalographic (rsEEG) alpha (8-10 Hz) source connectivity is abnormal in HIV-positive persons. Here we tested whether this abnormality may be associated with subcortical white matter vascular lesions in the cerebral hemispheres. Clinical, rsEEG, and magnetic resonance imaging (MRI) datasets in 38 HIV-positive persons and clinical and rsEEG datasets in 13 healthy controls were analyzed. Radiologists visually evaluated the subcortical white matter hyperintensities from T2-weighted FLAIR MRIs (i.e., Fazekas scale). In parallel, neurophysiologists estimated the eLORETA rsEEG source lagged linear connectivity from parietal cortical regions of interest. Compared to the HIV participants with no/negligible subcortical white matter hyperintensities, the HIV participants with mild/moderate subcortical white matter hyperintensities showed lower parietal interhemispheric rsEEG alpha lagged linear connectivity. This effect was also observed in HIV-positive persons with unimpaired cognition. This rsEEG marker allowed good discrimination (area under the receiver operating characteristic curve > 0.80) between the HIV-positive individuals with different amounts of subcortical white matter hyperintensities. The parietal rsEEG alpha source connectivity is associated with subcortical white matter vascular lesions in HIV-positive persons, even without neurocognitive disorders. Those MRI-rsEEG markers may be used to screen HIV-positive persons at risk of neurocognitive disorders.

Identifiants

pubmed: 37844524
pii: S1388-2457(23)00733-2
doi: 10.1016/j.clinph.2023.09.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-27

Informations de copyright

Copyright © 2023 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Auteurs

Claudio Babiloni (C)

Department of Physiology and Pharmacology "Erspamer", Sapienza University of Rome, Rome, Italy; Hospital San Raffaele Cassino, Cassino, (FR), Italy. Electronic address: claudio.babiloni@uniroma1.it.

Claudio Del Percio (C)

Department of Physiology and Pharmacology "Erspamer", Sapienza University of Rome, Rome, Italy.

Claudia Piervincenzi (C)

Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.

Filippo Carducci (F)

Department of Physiology and Pharmacology "Erspamer", Sapienza University of Rome, Rome, Italy.

Raffaele Ferri (R)

Oasi Research Institute - IRCCS, Troina, Italy.

Paolo Onorati (P)

Department of Physiology and Pharmacology "Erspamer", Sapienza University of Rome, Rome, Italy.

Ginevra Toma (G)

Department of Physiology and Pharmacology "Erspamer", Sapienza University of Rome, Rome, Italy.

Stefano Ferracuti (S)

Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.

Paolo Roma (P)

Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.

Valentina Correr (V)

Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.

Francesco Di Campli (F)

Infectious Diseases, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.

Antonio Aceti (A)

Infectious Diseases, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.

Marco Salvatore (M)

IRCCS Synlab SDN, Naples, Italy.

Andrea Soricelli (A)

IRCCS Synlab SDN, Naples, Italy; Department of Motor Sciences and Healthiness, University of Naples Parthenope, Naples, Italy.

Elisabetta Teti (E)

Clinical Infectious Diseases, University of Rome "Tor Vergata", Rome, Italy.

Alfredo Pennica (A)

Infectious Diseases, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.

Loredana Sarmati (L)

Clinical Infectious Diseases, University of Rome "Tor Vergata", Rome, Italy.

Vincenzo Vullo (V)

Department of Public Health and Infectious Diseases, Umberto I Hospital, Sapienza University of Rome, Rome, Italy.

Gabriella D'Ettorre (G)

Department of Public Health and Infectious Diseases, Umberto I Hospital, Sapienza University of Rome, Rome, Italy.

Claudio Mastroianni (C)

Department of Public Health and Infectious Diseases, Umberto I Hospital, Sapienza University of Rome, Rome, Italy.

Nikolaos Petsas (N)

IRCCS NEUROMED, Pozzilli, IS, Italy.

Patrizia Pantano (P)

Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy; IRCCS NEUROMED, Pozzilli, IS, Italy.

Roberto Floris (R)

Diagnostic and Interventional Radiology, University of Rome "Tor Vergata", Rome, Italy.

Fabrizio Stocchi (F)

IRCCS San Raffaele, Rome, Italy; Telematic University San Raffaele, Rome, Italy.

Massimo Andreoni (M)

Clinical Infectious Diseases, University of Rome "Tor Vergata", Rome, Italy.

Giovanni Di Perri (G)

Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin, Italy.

Andrea Calcagno (A)

Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin, Italy.

Giuseppe Noce (G)

IRCCS Synlab SDN, Naples, Italy.

Classifications MeSH